BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34632855)

  • 21. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
    Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
    Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
    Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
    Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Different Molecular Subtypes of Breast Cancer.
    Liang X; Li Z; Zhang L; Wang D; Tian J
    Ultrason Imaging; 2020 Nov; 42(6):261-270. PubMed ID: 33019918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.
    Pan J; Tong W; Luo J; Liang J; Pan F; Zheng Y; Xie X
    Br J Radiol; 2020 Aug; 93(1112):20200195. PubMed ID: 32463295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
    Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
    Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
    BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion.
    Zhang HP; Bai M; Gu JY; He YQ; Qiao XH; Du LF
    World J Gastroenterol; 2018 Feb; 24(6):744-751. PubMed ID: 29456413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity.
    Lehotska V; Rauova K; Vanovcanova L
    Neoplasma; 2018; 65(1):124-131. PubMed ID: 29322796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Diagnostic Model for Breast Lesions With Enlarged Enhancement Extent on Contrast-Enhanced Ultrasound Improves Malignancy Prediction.
    Weng H; Zhao Y; Xu Y; Hong Y; Wang K; Huang P
    Ultrasound Med Biol; 2023 Jul; 49(7):1535-1543. PubMed ID: 37012097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
    Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
    Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
    Jung EM; Jung F; Stroszczynski C; Wiesinger I
    Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.
    Fujimitsu R; Shimakura M; Urakawa H; Morita A; Shinagawa Y; Sakamoto K; Yoshimitsu K
    Jpn J Radiol; 2016 Jul; 34(7):508-14. PubMed ID: 27142527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.
    Wang X; Xu P; Wang Y; Grant EG
    Acta Radiol; 2011 Apr; 52(3):248-55. PubMed ID: 21498359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast enhanced ultrasound versus multiphasic contrast enhanced computed tomography in evaluation of gallbladder lesions.
    Boddapati SB; Lal A; Gupta P; Kalra N; Yadav TD; Gupta V; Dass A; Srinivasan R; Singhal M
    Abdom Radiol (NY); 2022 Feb; 47(2):566-575. PubMed ID: 34874479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional shear wave elastography for differential diagnosis between mastitis and breast malignancy.
    Liu SQ; Liu YP; Zhou BG; Deng XH; Li XL; Xiang LH; Ren WW; Xu HX
    Clin Hemorheol Microcirc; 2018; 70(3):347-354. PubMed ID: 29710692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of multimodality imaging in the diagnosis of breast lesions with calcification: A retrospective study.
    Tong W; Zhang X; Luo J; Pan F; Liang J; Huang H; Li M; Cheng M; Pan J; Zheng Y; Xie X
    Clin Hemorheol Microcirc; 2020; 76(1):85-98. PubMed ID: 32538829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfusion analysis of benign parotid gland tumors by contrast-enhanced ultrasonography (CEUS).
    Welkoborsky HJ; Albers M; Küstermeyer J
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4137-4146. PubMed ID: 35230508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.